GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yunnan Baiyao Group Co Ltd (SZSE:000538) » Definitions » Research & Development

Yunnan Baiyao Group Co (SZSE:000538) Research & Development : ¥336 Mil (TTM As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is Yunnan Baiyao Group Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Yunnan Baiyao Group Co's Research & Development for the three months ended in Dec. 2023 was ¥117 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ¥336 Mil.

Yunnan Baiyao Group Co Research & Development Historical Data

The historical data trend for Yunnan Baiyao Group Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yunnan Baiyao Group Co Research & Development Chart

Yunnan Baiyao Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 173.89 181.08 331.36 336.72 336.01

Yunnan Baiyao Group Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 128.86 64.09 80.73 73.79 117.41

Yunnan Baiyao Group Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥336 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yunnan Baiyao Group Co  (SZSE:000538) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Yunnan Baiyao Group Co Research & Development Related Terms

Thank you for viewing the detailed overview of Yunnan Baiyao Group Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Yunnan Baiyao Group Co (SZSE:000538) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yunnan Baiyao Group Co Ltd (SZSE:000538) » Definitions » Research & Development
Comparable Companies
SHSE:600085 SHSE:600196 SZSE:000963 SZSE:002001 SZSE:000999 SZSE:000661 SHSE:688506 SHSE:600332 SZSE:000423 SHSE:600566 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA TSE:4507 VTRS NBIX XSWX:SDZ
Traded in Other Exchanges
N/A
Address
No. 3686, Baiyao Street, Chancheng District, Yunnan Province, Kunming, CHN, 650500
Website
http://www.yunnanbaiyao.com.cn
Yunnan Baiyao Group Co Ltd is engaged in the manufacturing and marketing of medicines, which includes herbal products, daily health products, raw medicine, drug classics and among others.

Yunnan Baiyao Group Co (SZSE:000538) Headlines

No Headlines